Bioventus Inc - Class A (BVS) Company Profile & Statistics

Bioventus Inc - Class A
BVS
(Nasdaq - US)
Closed
13.72
+0.14 (+1.03%)
in:usd•As of: Nov 04, 2024 15:59 UTC -5
Open
13.60
High
14.35
Low
13.41

About Bioventus Inc - Class A

CEO

Robert E. Claypoole

Headquarters

4721 emperor boulevard, suite 100

durham, nc 27703, united states

Auditor

GRANT THORNTON LLP

Employees

970

Share Holders

N/A

Website

http://www.bioventus.com

Industry

medical specialties

Sector

health technology

Company Overview

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

Bioventus Inc - Class A Statistics

Valuation Measures

Market Capitalization ²	1.10B
Enterprise Value	1.45B
Enterprise Value/EBITDA (ttm)	47.25
Price to Earnings Ratio (ttm)	35.74
Price to Book (mrq)	5.82
Price to Sales (ttm)	2.05
Price to Cash (ytd)	17.17

Profitability

Gross Margin (ttm)	66.45%
Operating Margin (ttm)	5.72%
Profit Margin (ttm)	-7.49%
Return on Equity (ttm)	14.39%
Return on Invested Capital (ttm)	-9.82%
Return on Assets (ttm)	3.83%

Income Statement

Revenue (ttm)	536.89M
Revenue Per Share (ttm)	6.63
Gross Profit (ttm)	357.17M
EBITDA (ttm)³	30.71M
Net Income Avi to Common (ttm)	-41.96M
Diluted EPS (ttm)	-0.66

Share Statistics

Beta (5Y Monthly)	0.88
52-Week Change	281.64%
S&P500 52-Week Change	30.85%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	80.97M
Dividend Yield	0.00%
Float ⁴	54.33M
% Held by Insiders	32.90%
% Held by Institutions	62.94%

Balance Sheet

Total Cash (mrq)	31.99M
Total Cash Per Share (mrq)	0.40
Total Debt (mrq)	383.28M
Total Debt/Equity (mrq)	202.73%
Current Ratio (mrq)	1.33%
Quick Ratio (mrq)	0.96%
Book Value Per Share (mrq)	2.34

Cash Flow

Operating Cash Flow Per Share (ytd)	0.14
Free Cash Flow (ytd)	8.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Bioventus Inc - Class A

Trade With A Regulated Broker